- Potential benefitReduces out-of-pocket spending for Medicare beneficiaries receiving ASC facility services.
- Potential benefitProvides a clear, predictable maximum coinsurance amount tied to the inpatient deductible.
- Potential benefitMaintains supplier revenue by requiring Medicare to pay suppliers the coinsurance reduction amount.
Medicare Beneficiary Co-Pay Fairness Act
Read twice and referred to the Committee on Finance.
This bill (Medicare Beneficiary Co-Pay Fairness Act) limits beneficiary coinsurance for facility services provided during a surgical procedure in an ambulatory surgical center (ASC). If the coinsurance would exceed the inpatient hospital deductible for that year, the Secretary must reduce the beneficiary’s coinsurance to that deductible and pay the supplier the difference.
Cost burden: liberals emphasize beneficiary relief; conservatives emphasize taxpayer cost.
Relative to its intended legislative type, this bill is a narrowly targeted substantive change that is clearly stated and sufficiently specific about the legal cap and the responsible federal actor, but it lacks several practical implementation and fiscal details that would normally accompany changes to Medicare payment rules.
This bill (Medicare Beneficiary Co-Pay Fairness Act) limits beneficiary coinsurance for facility services provided during a surgical procedure in an ambulatory surgical center (ASC).
If the coinsurance would exceed the inpatient hospital deductible for that year, the Secretary must reduce the beneficiary’s coinsurance to that deductible and pay the supplier the difference.
The change applies to services furnished on or after January 1, 2026.
Technically straightforward and popular in concept, but creates uncapped Medicare outlays and lacks offsets, lowering standalone prospects.
Relative to its intended legislative type, this bill is a narrowly targeted substantive change that is clearly stated and sufficiently specific about the legal cap and the responsible federal actor, but it lacks several practical implementation and fiscal details that would normally accompany changes to Medicare payment rules.
Cost burden: liberals emphasize beneficiary relief; conservatives emphasize taxpayer cost.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesIncreases federal Medicare outlays because Medicare covers the coinsurance reduction paid to suppliers.
- Potential burdenReduces beneficiary price signals, which could increase demand or utilization of ASC services.
- Potential burdenMay shift care and revenues between hospitals and ASCs, altering provider market dynamics.
Why the argument around this bill splits.
Cost burden: liberals emphasize beneficiary relief; conservatives emphasize taxpayer cost.
Likely supportive because it reduces out-of-pocket costs for Medicare beneficiaries and protects patients from high ASC facility charges.
Seen as a consumer-protection and access measure for older and low-income patients.
Cautious support if budgetary impact is modest and guardrails exist.
Sees clear beneficiary relief but wants cost estimates and evaluation of unintended incentives before full endorsement.
Likely skeptical because it increases federal spending and shifts costs from beneficiaries to taxpayers.
Views it as a federal expansion without clear offsets or targeted need-testing.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically straightforward and popular in concept, but creates uncapped Medicare outlays and lacks offsets, lowering standalone prospects.
- No CBO or cost estimate included
- Magnitude of increased Medicare spending unknown
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Cost burden: liberals emphasize beneficiary relief; conservatives emphasize taxpayer cost.
Technically straightforward and popular in concept, but creates uncapped Medicare outlays and lacks offsets, lowering standalone prospects.
Relative to its intended legislative type, this bill is a narrowly targeted substantive change that is clearly stated and sufficiently specific about the legal cap and the responsible federal actor, but it lacks several…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.